BCR and acute leukemia: We were able to directly cross-check the clinically most relevant RTK mutations in acute leukemia (i.e. FLT3-ITD, KIT D816V/Y, BCR/ABL1) transfected into an isogenic Ba/F3 background against a panel of leukemic cell lines harboring a corresponding RTK mutation.